The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care.

{"article_title":"The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care.","author":"\"Dickerson, Bradford C , Atri, Alireza , Clevenger, Carolyn , Karlawish, Jason , Knopman, David , Lin, Pei-Jung , Norman, Mary , Onyike, Chiadi , Sano, Mary , Scanland, Susan , Carrillo, Maria\"","journal_title":"Alzheimer's & dementia : the journal of the Alzheimer's Association","issn":"1552-5279 ; Electronic","isbn":"","publication_date":"20250101","volume":"21","issue":"1","first_page":"e14337","page_count":"","accession_number":"39713957","doi":"10.1002\/alz.14337","publisher":"John Wiley & Sons, Ltd","doctype":"Journal Article; Practice Guideline","subjects":"Neurology","interest_area":["Neurology"],"abstract":"US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer's disease (AD) or a related dementia (ADRD) are two decades old. This evidence-based guideline was developed to empower all clinicians to implement a structured approach for evaluating a patient with symptoms that may represent clinical AD\/ADRD. An expert workgroup conducted a review of 7374 publications (133 met inclusion criteria) and developed recommendations as steps in an evaluation process. This summary briefly reviews core recommendations and details specialist recommendations of a high-quality, evidence-supported evaluation process aimed at characterizing, diagnosing, and disclosing the patient's cognitive functional status, cognitive-behavioral syndrome, and likely underlying brain disease so that optimal care plans to maximize patient\/care partner dyad quality of life can be developed; a companion article summarizes primary care recommendations. If clinicians use the recommendations in this guideline and health-care systems provide adequate resources, outcomes should improve in most patients in most practice settings. HIGHLIGHTS: US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer's disease (AD) or related dementias (ADRD) are decades old and aimed at specialists. This evidence-based guideline was developed to empower all-including primary care-clinicians to implement a structured approach for evaluating a patient with symptoms that may represent clinical AD\/ADRD. This summary focuses on recommendations appropriate for specialty practice settings, forming key elements of a high-quality, evidence-supported evaluation process aimed at characterizing, diagnosing, and disclosing the patient's cognitive functional status, cognitive-behavioral syndrome, and likely underlying brain disease so that optimal care plans to maximize patient\/care partner dyad quality of life can be developed; a companion article summarizes primary care recommendations. If clinicians use this guideline and health-care systems provide adequate resources, outcomes should improve in most patients in most practice settings.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=39713957&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Dickerson BC, Atri A, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M","Journal_Info":"Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2025-01-01","Source":"Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2025 Jan; Vol. 21 (1), pp. e14337. Date of Electronic Publication: 2024 Dec 23.","Languages":"English","Electronic_ISSN":"1552-5279","MeSH_Terms":"Alzheimer Disease*\/diagnosis , Alzheimer Disease*\/psychology , Counseling* , Disclosure* , Cognitive Dysfunction*\/diagnosis, Humans ; United States","Subjects":"Humans, United States, Alzheimer Disease diagnosis, Alzheimer Disease psychology, Counseling, Disclosure, Cognitive Dysfunction diagnosis","Title_Abbreviations":"Alzheimer's & dementia : the journal of the Alzheimer's Association","Volume":"21"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"39713957","RelevancyScore":"949","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"948.988342285156"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=39713957&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=39713957&authtype=shib&custid=ns346513&group=main&profile=eds"}